SURMATRIX Trademark

Trademark Overview


On Monday, April 7, 2025, a trademark application was filed for SURMATRIX with the United States Patent and Trademark Office. The USPTO has given the SURMATRIX trademark a serial number of 99124349. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, March 12, 2026. This trademark is owned by Surgenex Holdings, LLC. The SURMATRIX trademark is filed in the Pharmaceutical Products category with the following description:

Amniotic liquid human allograft tissue; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for the treatment of wounds, ulcers, burns, scars, surgical incisions, joint pain, osteoarthritis, tendinopathy, soft tissue repair, sports injuries, Mohs surgery scarring, and post-operative pain; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft tissue; Flowable human allograft tissue derived from donated human amniotic membrane; Bone void fillers consisting of biological materials, namely, bone graft putty derived from demineralized bone matrix (DBM) for medical purposes; Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder...

General Information


Serial Number99124349
Word MarkSURMATRIX
Filing DateMonday, April 7, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, March 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAmniotic liquid human allograft tissue; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for the treatment of wounds, ulcers, burns, scars, surgical incisions, joint pain, osteoarthritis, tendinopathy, soft tissue repair, sports injuries, Mohs surgery scarring, and post-operative pain; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft tissue; Flowable human allograft tissue derived from donated human amniotic membrane; Bone void fillers consisting of biological materials, namely, bone graft putty derived from demineralized bone matrix (DBM) for medical purposes; Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder; Human allograft bone and tissue; Human allograft tissue in the nature of demineralized bone matrix used for use in surgical procedures; Surgical implants for the bone comprising living tissue in the nature of demineralized bone matrix for use in surgical procedures; Biological demineralized bone matrix human allograft tissue intended for subsequent implantation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSurgenex Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85260
US

Trademark Events


Event DateEvent Description
Monday, April 7, 2025NEW APPLICATION ENTERED
Monday, April 7, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 7, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 3, 2025ASSIGNED TO EXAMINER
Wednesday, September 10, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 10, 2025NON-FINAL ACTION E-MAILED
Wednesday, September 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 4, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 8, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 8, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, March 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 5, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 6, 2026NON-FINAL ACTION WRITTEN
Friday, March 6, 2026NON-FINAL ACTION E-MAILED
Friday, March 6, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 12, 2026EXAMINERS AMENDMENT -WRITTEN
Thursday, March 12, 2026EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2026EXAMINER'S AMENDMENT ENTERED
Thursday, March 12, 2026APPROVED FOR PUB - PRINCIPAL REGISTER